David Johnston

Dave brings over thirty years of senior financial leadership experience. Most recently he was Chief Financial Officer for ImmunoGen, Inc. an oncology focused biotech based in Waltham, MA. During his tenure at ImmunoGen, he led several public offerings as well as a creative, non-dilutive royalty financing. Prior to ImmunoGen, Dave served as CFO for Aveo Oncology and Genzyme Biosurgery where he lead both of their initial public offerings as well as leading several strategic initiatives, both on the buy-side as well as the sell-side.